Tao G, Workowski K, Bowden KE, et al. - As per the Centers for Disease Control and Prevention (CDC) 2015 sexually transmitted disease treatment guidelines, specific regimens are recommended for chlamydia and dual therapy are recommended for gonorrhea to reduce antimicrobial-resistant gonorrhea. Researchers conducted this study with the aim to determine adherence to these recommendations at private practices in the United States. The OptumLabs Data Warehouse, a comprehensive, longitudinal data asset with deidentified persons with linked commercial insurance claims and clinical information, was utilized to recognize persons aged 15 to 60 years who had valid nucleic acid amplification testing results establishing urogenital or extragenital gonorrhea or chlamydia in 2016 to 2018. They identified 6,476 patients with positive gonorrhea test results and 26,847 patients with positive chlamydia test results. Only, 34.8% and 64.2% of these patients had evidence of receiving the CDC-recommended therapy, respectively. Hence, low rates of recommended gonorrhea and chlamydia treatment were identified according to the analysis of treatment claims and medical records from private settings.